Being proactive about health as we get older is important if we’re to keep diseases and chronic health conditions at bay – and it seems that, in terms of vaccinations, the respiratory syncytial virus (RSV) programme would be particularly beneficial for older people.
New research from the University of Strathclyde and Public Health Scotland has just revealed that hospital admissions for people aged between 75 and 79 were reduced by 62 per cent after the free RSV vaccine scheme was introduced in August last year.
What is RSV?
RSV is a very common and very infectious respiratory virus that impacts the breathing system and poses a very serious health risk for those who are most at risk, including older people.
The virus is spread via the coughs and sneezes of someone else carrying the virus, with symptoms including a runny or blocked nose, coughs/sneezes, tiredness and a high temperature, as well as sweatiness and chills.
If RSV becomes more serious and develops into something like pneumonia, you may experience symptoms such as an escalating cough, shortness of breath, faster breathing, wheezing or confusion.
There are various ways in which you can reduce the chances of contracting the virus, including:
– Cleaning surfaces regularly
– Not touching your eyes, nose or mouth if you have dirty hands
– Using disposable tissues and throwing them away as soon as they’ve been used
The RSV vaccine
The RSV vaccine is recommended for anyone aged between 75 and 79, helping to reduce the risks of serious complications, including pneumonia and bronchiolitis, which can cause serious breathing problems that can be life-threatening.
You can book your vaccination via your local GP surgery and they may get in touch with you to recommend that you have it, but note that you don’t have to be contacted before you book.
The vaccine itself is available all year round and is administered as an injection in the upper arm. You only need a single dose and you should be afforded protection for several years.
As with any vaccine, there is the risk of side-effects, including:
– Swelling or pain at the injection site
– Headache
– An aching body
Illness prevention
Commenting on the findings of the Strathclyde University study, professor Chris Robertson said: “Our data shows that the programme has had rapid success, not only in the reduction in hospital admissions linked to RSV in the age groups vaccinated but also in the extent of the vaccine uptake.
“People receiving the vaccination are protecting themselves and it will be important to maintain the uptake at high levels.”
The vaccine has been found to reduce the risks of RSV infection but, as with all medication, no vaccine is completely effective and you may still be infected even if you do have the vaccination. However, your illness should be less severe if you are vaccinated against RSV.
